Sparstolonin B attenuates hypoxia–reoxygenation-induced cardiomyocyte inflammation

Differential activation of Toll-like receptor-mediated apoptosis induced by hypoxia

(2015)   Oncotarget

Endogenous Damage-Associated Molecular Pattern Molecules at the Crossroads of Inflammation and Cancer

(2015) Geetha Srikrishna et al.   NEOPLASIA

Sparstolonin B suppresses lipopolysaccharide-induced inflammation in human umbilical vein endothelial cells

(2013) Qiaoli Liang et al.   ARCHIVES OF PHARMACAL RESEARCH

Inflammation in Myocardial Diseases

(2012) David J. Marchant et al.   CIRCULATION RESEARCH

The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease

(2012) Rolf Spirig et al.   Cardiology Research and Practice

The role of monocytes and inflammation in the pathophysiology of heart failure

(2011) Benjamin J. Wrigley et al.   EUROPEAN JOURNAL OF HEART FAILURE

Characterization of Sparstolonin B, a Chinese Herb-derived Compound, as a Selective Toll-like Receptor Antagonist with Potent Anti-inflammatory Properties

(2011) Qiaoli Liang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Ischemia and reperfusion—from mechanism to translation

(2011) Holger K Eltzschig et al.   NATURE MEDICINE

Endogenous toll-like receptor ligands and their biological significance

(2010) Li Yu et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Cardiomyocyte Toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemia

(2010) Reut Fallach et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Toll-Like Receptor Signaling Pathways and the Evidence Linking Toll-Like Receptor Signaling to Cardiac Ischemia/Reperfusion Injury

(2010) Yue Wang et al.   SHOCK

Myocardial TLR4 is a determinant of neutrophil infiltration after global myocardial ischemia: mediating KC and MCP-1 expression induced by extracellular HSC70

(2009) Lihua Ao et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Myocardial Ischemia/Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti–Toll-Like Receptor-2 Antibody

(2009) Fatih Arslan et al.   CIRCULATION

Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes

(2009) Carlos Gonzalez-Quesada et al.   Current Atherosclerosis Reports

Monocyte Chemoattractant Protein-1 (MCP-1): An Overview

(2009) Satish L. Deshmane et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Mechanisms of Toll-Like Receptor 4 (TLR4)-Mediated Inflammation After Cold Ischemia/Reperfusion in the Heart

(2009) David J. Kaczorowski et al.   TRANSPLANTATION

Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases

(2008) Bruce Beutler   IMMUNOLOGICAL REVIEWS

Citocinas e proteínas de fase aguda do soro como marcadores de regressão da resposta inflamatória ao tratamento da tuberculose pulmonar

(2008) Eliana Peresi et al.   Jornal Brasileiro de Pneumologia

Unknown

(2008) John Klune et al.   MOLECULAR MEDICINE